Multiple endocrine neoplasia type 1 parathyroid adenoma development over time

被引:22
|
作者
Doherty, GM
Lairmore, TC
DeBenedetti, MK
机构
[1] Univ Michigan, Dept Surg, Taubman Ctr 2920, Ann Arbor, MI 48109 USA
[2] Washington Univ, Dept Surg, St Louis, MO 63110 USA
关键词
D O I
10.1007/s00268-004-7560-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
Multiple gland parathyroid disease is one of the hallmarks of multiple endocrine neoplasia (MEN) type 1. Often mislabeled parathyroid hyperplasia. the process is actually the development of multiple adenomas. Some clinicians have reported results of selective parathyroidectomy ill this group. removing only grossly enlarged glands. We argue that all the glands are at risk and should be addressed at any planned parathyroid intervention. Our hypothesis is that, given sufficient time, patients would all develop adenomas in each of the parathyroid glands. Our available data to address this issue are the parathyroidectomy results front a single institution series. Patients who had initial parathyroid exploration for hyperparathyroidism in the setting of MEN-1 were reviewed. This study includes those patients who half the weights of the resected glands documented; 23 men and 21 women met the criteria. The total weight of the parathyroid glands did not vary with the age of the patient at operation. However, the number of normal glands identified did vary significantly with age (p < 0.02). with older patients being less likely to have any normal parathyroid glands. Although total parathyroid weight may correlate with development of hypercalcemia and indications for operation, the involvement of multiple parathyroid glands in MEN-1 is a function of time, as independent events in each gland must occur. Given time, MEN-I patients all develop multiple gland disease. and this reality must be used in planning operative management for patients with this syndrome.
引用
收藏
页码:1139 / 1142
页数:4
相关论文
共 50 条
  • [31] Multiple Endocrine Neoplasia Type 1
    Brandi M.L.
    Reviews in Endocrine and Metabolic Disorders, 2000, 1 (4) : 275 - 282
  • [32] Multiple Endocrine Neoplasia Type 1
    Manoharan, Jerena
    Albers, Max B.
    Rinke, Anja
    Adelmeyer, Jan
    Goerlach, Jannis
    Bartsch, Detlef K.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2024, 121 (16):
  • [33] Multiple endocrine neoplasia type 1
    Wong, FK
    Burgess, J
    Nordenskjöld, M
    Larsson, C
    Teh, BT
    SEMINARS IN CANCER BIOLOGY, 2000, 10 (04) : 299 - 312
  • [34] Multiple endocrine neoplasia in a dog: thyroid adenocarcinoma, parathyroid adenoma and neuroendocrine abdominal carcinoma
    Schneider, Annika
    Engelhardt, Peter
    KLEINTIERPRAXIS, 2018, 63 (01): : 4 - 11
  • [35] Tumors of the pituitary, pancreas, and parathyroid glands in a patient with multiple endocrine neoplasia type 1
    Simcic, KJ
    Moreno, AJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22): : 1602 - 1602
  • [36] Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1 - Discussion
    Lee, CH
    Hellman, P
    Lairmore, TC
    SURGERY, 1998, 124 (06) : 999 - 999
  • [37] PARATHYROID HYPERPLASIA IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 - A PATHOLOGICAL AND IMMUNOHISTOCHEMICAL REAPPRAISAL
    HARACH, HR
    JASANI, B
    HISTOPATHOLOGY, 1992, 20 (04) : 305 - 313
  • [38] GIANT MEDIASTINAL PARATHYROID ADENOMAS AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 1: A DIAGNOSTIC CONUNDRUM
    Gautam, A.
    Rastogi, A.
    Bhadada, S. K.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (01) : 118 - 123
  • [39] Questions and Controversies About Parathyroid Pathophysiology in Children With Multiple Endocrine Neoplasia Type 1
    Marx, Stephen J.
    Lourenco, Delmar M., Jr.
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [40] Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: An unusual presentation of multiple endocrine neoplasia type 2A?
    Rone, JK
    Lane, AG
    Grinkemeyer, MD
    THYROID, 1998, 8 (09) : 781 - 785